Jade Biosciences, Inc. Common Stock JBIO Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Liquidity | |||||
| Current ratio | 21.1×+15.3× | 5.8×-1.2× | 7×-9.9× | 16.9×-51.5× | |
| Leverage | |||||
| Debt-to-equity | 0×— | —— | 0×0.0× | 0×0.0× | |
| Per Share | |||||
| Book value per share | $10.60+171% | -$14.83-457% | $4.16-19.7% | $5.18-63.1% | |
| Valuation | |||||
| Market capitalization | $1.33B+318% | —— | —— | —— | |
| Price / book | 4.5×— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Jade Biosciences, Inc. Common Stock's ratios come from?
- Every ratio is computed from Jade Biosciences, Inc. Common Stock's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.